ProCE Banner Activity

CE / CME

Considering Long-acting ART With Viremia and Past Adherence Challenges: Peer Perspectives

Video

Watch as experts discuss the subtleties of deciding among HIV treatment options in people with adherence challenges. They’ll explore resistance considerations, recommendations concerning proviral DNA genotyping, and how to interpret guidelines for long-acting ART in this population, including its potential risks and benefits.

Nurses: 0.75 Nursing contact hour

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: August 14, 2024

Expiration: August 13, 2025

Share

Faculty

Aadia I. Rana

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Laurence Slama

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu University Hospital
University Paris Cité
Paris, France

Provided by

Provided by Clinical Care Options, LLC, in partnership with HIV-ASSIST

ProCE Banner

Supporters

Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Partners

HIV-ASSIST

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, nurses and other healthcare professionals who are involved in the provision of antiretroviral therapy for people living with HIV.

Program Learning Goal

The goal of this program is to enhance learners’ competence in making optimal, evidence-based antiretroviral treatment strategies in specific scenarios where many HIV treaters currently make suboptimal decisions.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Apply evidence-based strategies for complex clinical scenarios, underpinned by the latest scientific data and clinical recommendations

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Aadia I. Rana, MD, has no relevant financial relationships to disclose.

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu University Hospital
University Paris Cité
Paris, France

Laurence Slama, MD, PhD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, ViiV.

The planners and content peer reviewers from Clinical Care Options, LLC and HIV-ASSIST do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 14, 2024, through August 13, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC and HIV-ASSIST. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-24-184-H02-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.